Three generic drug makers’ challenge to the validity of a Bayer AG patent protecting its blockbuster blood-thinning drug ...
By extending their monopoly on a drug, companies prevent generics and other competitors from driving down prices. But increasing transparency can help prevent Big Pharma from gaming the patent system.
In the final keynote address of IPWatchdog’s three-day 2025 Women’s IP Forum, the Honorable Kathleen O’Malley, former Circuit ...
The USPTO’s revival of a key affordability-first search patent puts MLSs, brokers, and proptech vendors at a crossroads over ...
Hefei Lunzha's Breakthrough Patent: Significant Reduction in Installation and Disassembly Time ...
A bipartisan consensus is quietly emerging in Washington. Lawmakers from both parties are working with each other and the ...
The race to protect intellectual property in multiple jurisdictions has become a defining feature of the global innovation economy. For inventors, startups, and ...
Radar Finance reported that according to the Tianyancha App, on September 23, the patent application for "Magnetorheological ...
Bausch Health and Teva Pharmaceuticals were sued on Monday for allegedly conspiring to delay sales of a generic version of ...
Sauvegarder Investment Management ("SIM IP"), a global leader in intellectual property-based investment and monetization, is ...
Judge Pauline Newman has served with distinction on the U.S. Court of Appeals for the Federal Circuit since her appointment by President Ronald Reagan in 1984. Her career has been marked by a ...
Stellantis filed this patent in Germany, and the basic idea seems pretty simple. The car's computers keep track of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback